Odisha Approves Pharma & MedTech Policy to Build Sector Hubs & Boost Investment

The new policy will help Odisha build a competitive ecosystem for pharmaceutical and MedTech manufacturing, offering investors modern infrastructure, incentives and streamlined approvals to scale operations.

The Odisha Cabinet has approved a new Pharma & MedTech Policy designed to position the state as a competitive hub for pharmaceutical manufacturing, medical device production, and healthcare innovation.

The policy is expected to drive large-scale investment and accelerate the development of sector-specific industrial clusters equipped with advanced infrastructure and streamlined regulatory processes.

Announcing the approval, Chief Secretary Pradeep Kumar Jena said the new policy will give Odisha a stronger presence in India’s expanding healthcare manufacturing landscape. “The Pharma and MedTech sector have significant potential for growth,” he noted.

Adding that the policy aims to support investors with incentives, land availability and plug-and-play facilities to help companies scale faster.

The initiative includes the creation of dedicated industrial hubs to attract pharmaceutical companies, bulk drug manufacturers, diagnostic device producers and MedTech innovators.

Industries Secretary Hemant Sharma highlighted that the policy is designed to help Odisha tap into rising demand for domestic manufacturing. “We see this as an opportunity to build a reliable, high-quality ecosystem that supports both innovation and large-scale production,” he said.

By expanding manufacturing capacities within the state, Odisha aims to strengthen supply chains and provide a conducive environment for research, technology upgrades and global export opportunities.

The Cabinet also emphasized the policy’s potential to create high-skilled employment and foster industry-academia collaboration across pharmaceuticals and MedTech.

Hemant Sharma mentioned the state is prepared to offer investor-friendly support. “Our focus is on creating long-term value for companies and ensuring Odisha becomes a preferred destination for the life sciences sector.”

With the policy now in place, the government is expected to initiate development work within planned industrial zones and begin outreach to domestic and international manufacturers.

Related Posts

Ayush export declines by 7.4% in first nine months of FY 26

New Delhi:  Exports of Ayush and herbal products have reported a decline of 7.42% during the first nine months of the fiscal year 2025-26, compared to the same period of…

Three State Drug Testing Laboratories Functional in Jammu Kashmir: GoI

SRINAGAR:  The Government of India on Friday informed the Lok Sabha that Jammu and Kashmir has three State Drug Testing Laboratories funded under the centrally sponsored scheme for strengthening the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ayush export declines by 7.4% in first nine months of FY 26

Ayush export declines by 7.4% in first nine months of FY 26

Three State Drug Testing Laboratories Functional in Jammu Kashmir: GoI

Three State Drug Testing Laboratories Functional in Jammu Kashmir: GoI

One more illegal drug manufacturing factory busted in Gaya, 9th Kingpin Nabbed amid Massive Seizure

One more illegal drug manufacturing factory busted in Gaya, 9th Kingpin Nabbed amid Massive Seizure

ICMR mandates clinical trials to focus on Indian demography, lifestyle

ICMR mandates clinical trials to focus on Indian demography, lifestyle

India’s Medical Devices Market Is Set To Hit $50 Billion By 2030: Rubix Report

India’s Medical Devices Market Is Set To Hit $50 Billion By 2030: Rubix Report

Muradnagar Police Bust Fake Liver-52 DS Herbal Medicine Racket: Three Arrested

Muradnagar Police Bust Fake Liver-52 DS Herbal Medicine Racket: Three Arrested